These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Acute renal failure due to phenazopyridine (Pyridium) overdose: case report and review of the literature. Onder AM; Espinoza V; Berho ME; Chandar J; Zilleruelo G; Abitbol C Pediatr Nephrol; 2006 Nov; 21(11):1760-4. PubMed ID: 16897003 [TBL] [Abstract][Full Text] [Related]
14. Acquired methemoglobinemia and hemolytic anemia after usual doses of phenazopyridine. Jeffery WH; Zelicoff AP; Hardy WR Drug Intell Clin Pharm; 1982 Feb; 16(2):157-9. PubMed ID: 7075467 [TBL] [Abstract][Full Text] [Related]
15. 2,6-Diamino-5-hydroxy-3-(phenylazo)pyridine, a novel metabolite of phenazopyridine in the rat. Bailey K; Thomas BH; Vézina M; Whitehouse LW; Zeitz W; Solomonraj G Drug Metab Dispos; 1983; 11(3):277-8. PubMed ID: 6135589 [No Abstract] [Full Text] [Related]
16. Protracted methemoglobinemia after phenazopyridine overdose in an infant. Christensen CM; Farrar HC; Kearns GL J Clin Pharmacol; 1996 Feb; 36(2):112-6. PubMed ID: 8852386 [TBL] [Abstract][Full Text] [Related]
18. Effect of adsorption of phenazopyridine hydrochloride on its bioavailability in human. Meshali MM; El-Sabbagh H Pharmazie; 1981 Dec; 36(12):867-8. PubMed ID: 7330091 [No Abstract] [Full Text] [Related]
19. Effect of some additives on the properties of phenazopyridine hydrochloride granules and their corresponding tablets. el-Sabbagh HM; Meshali M; Ghanem A; Abdel-Aleem H Pharmazie; 1984 Jun; 39(6):404-6. PubMed ID: 6483945 [TBL] [Abstract][Full Text] [Related]
20. Methemoglobinemia and hemolytic anemia after phenazopyridine hydrochloride (Pyridium) administration in end-stage renal disease. Fincher ME; Campbell HT South Med J; 1989 Mar; 82(3):372-4. PubMed ID: 2922627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]